Skip to main content Skip to main navigation
Rijksoverheid logo | to homepage of RIVM National Institute for Public Health and the Environment Ministry of Health, Welfare and Sport
  • Nederlands
  • English
RIVM Committed to health and sustainability
  • Home
  • Topics
  • About RIVM
  • Publications
  • International
  • Contact
  • Agenda
  • MijnRIVM
  • Nederlands
  • English
  • Home
  • Page

Page

Back to topic

Social media house rules

Everyone is welcome to engage with us on social media, but we do ask that you respect our house rules. 

Protocols EURL-PH-VBV

Scientific report RIVM

RIVM staff are all specialists in a certain field. Nevertheless, they are not ‘pure’ scientists but they combine scientific expertise with a great desire to serve society at large. Knowledge should be of practical use in addressing current social issues such as sustainability, zoonotic diseases or nanotechnology.

Measles and pregnancy

Pregnant people who are not vaccinated against measles and have never had measles themselves have a higher risk of severe illness due to measles. Read more about it here and find out what you can do to keep from becoming ill.

Vaccination against measles

Measles is a virus that can make people very ill. The MMR vaccination offers effective protection against measles. Read more about the MMR vaccination and protection against measles in the Netherlands on this page. You can also read about how to find out if you are protected against the disease.

Measles at school or childcare

Are there people with measles in your city or the surrounding area? You may have questions. Read more on this page about the measures that apply if a person with measles has been at the school or childcare facility – and what you should do if your child played with another child who has measles.

Annual reporting on surveillance of acute respiratory infections 2024/2025 – Disease burden of COVID-19 and influenza

This page provides information about the estimated disease burden of COVID-19 and influenza, expressed in DALYs.Expressing disease burden in a single measure makes it possible to compare the loss of health caused by different diseases. Such comparison is important for prioritizing policies and resources for combating (infectious) diseases. A commonly used measure for disease burden is the disability-adjusted life year, or DALY. Disease burden in DALYs reflects the sum of healthy life years lost due to illness and disability (years lived with disability: YLD) and due to premature death (years of life lost: YLL). Detailed descriptions of the methods used can be found in a previous edition of the State of Infectious Diseases (in Dutch)(PDF). This page presents estimates of DALYs for COVID-19 and influenza. The disease burden of long-term effects after a SARS-CoV-2 infection, known as the 'post-COVID syndrome', is not included. A more extensive description of these two infectious diseases, as well as 35 other infectious diseases in the Netherlands, is published in the State of Infectious Diseases 2024 (in Dutch). 

Reports and publications

Overview of all RIVM reports and scientific publications on endocrine disrupting chemicals.

Projects and collaborations

RIVM takes part in various national and international research projects studying endocrine disrupting chemicals. These projects aim to gather data and develop testing methods to establish whether a substance qualifies as an endocrine disrupting chemical. The European Commission, the Dutch Research Council (NWO) and RIVM have made funding available for research. Given below is a list of projects on endocrine disrupting chemicals in which RIVM participates.

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • › Next ›
  • » Last »

Service

  • Contact
  • Information for the press
  • Working for RIVM
  • Complaints
  • Submitting WOO requests to RIVM
  • Doing business with RIVM
  • Huisregels sociale media

About this site

  • Cookies
  • Privacy
  • Accessibility
  • Disclaimer and copyright
  • Coordinated Vulnerability Disclosure
  • Website archive

Languages

  • English
  • Nederlands

Follow us

  • RIVM Newsletters
  • RSS feed
  • X Twitter
  • Facebook
  • LinkedIn
  • Youtube
  • Instagram
  • Mastodon